Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors


DARMSTADT, Germany, January 24, 2019 /PRNewswire/ -- Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical ... Lees verder

Bron: ANP Pers support
Geplaatst: 24 jan 2019 - 14:01